METTL9-SLC7A11轴通过抑制铁亡促进肝细胞癌的进展
Fangfang Bi1,2, Yuxiong Qiu1,2, Zongfeng Wu1,2
1State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Cell death discovery
|November 28, 2023
概括
甲基转移酶类蛋白9 (METTL9) 通过抑制铁亡,促进肝细胞癌 (HCC) 的进展. 向METTL9为HCC治疗提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 甲基转移酶类蛋白9 (METTL9) 被认为是各种癌症中的癌基因.
- 在肝细胞癌 (HCC) 中METTL9的特定作用以前没有被阐明.
研究的目的:
- 研究METTL9在HCC的发展和进展中的功能和分子机制.
- 为了确定METTL9表达在HCC患者的预后意义.
主要方法:
- 对HCC组织中METTL9表达的分析以及与患者存活率的相关性.
- 在体外和体内实验涉及METTL9敲击和HCC细胞过度表达的实验.
- 研究涉及SLC7A11和ferroptosis的分子途径.
- 在HCC患者衍生异种移植 (PDX) 模型中对METTL9向的评估.
主要成果:
- 在HCC中,METTL9的表达显著升高,与糟糕的生存结果相关.
- 抑制METTL9抑制HCC细胞活力,迁移和入侵,而过度表达则增强了这些过程.
- 通过降低SLC7A11表达,METTL9敲除促进铁亡,从而阻碍HCC的进展.
- 向METTL9有效地抑制了HCC患者衍生的异种移植的生长.
结论:
- METTL9在促进HCC的发展和进展方面发挥着关键的致癌作用.
- 通过通过SLC7A11.11调节铁亡,METTL9影响HCC.
- METTL9代表了HCC的一个有前途的治疗点,可能通过调节铁亡.
更多相关视频
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
19.0K
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
413
相关概念视频
01:16Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K